ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Copy number variants and therapeutic response to antidepressant medication in major depressive disorder

Tansey, K. E.*; Rucker, J. J. H.; Kavanagh, D. H.; Guipponi, M.; Perroud, N.; Bondolfi, G.; Domenici, E.; Evans, D. M.; Hausers, J.; Henigsberg, N.; Jerman, B.; Maier, W.; Mors, O.; O'Donovan, M.; Peters, T. J.; Placentino, A.; Rietschel, M.; Souery, D.; Aitchison, K. J.; Craig, I.; Farmer, A.; Wendland, J. R.; Malafosse, A.; Lewis, G.; Kapur, S.; McGuffin, P.; Uher, R.cent inst mental hlth
PHARMACOGENOMICS JOURNAL2014-8DOI: 10.1038/tpj.2013.51
16被引1阅读
引用收藏
分享

摘要

It would be beneficial to find genetic predictors of antidepressant response to help personalise treatment of major depressive disorder (MDD). Rare copy number variants (CNVs) have been implicated in several psychiatric disorders, including MDD, but their role in antidepressant response has yet to be investigated. CNV data were available for 1565 individuals with MDD from the NEWMEDS (Novel Methods leading to New Medications in Depression and Schizophrenia) consortium with prospective data on treatment outcome with either a serotonergic or noradrenergic antidepressant. No association was seen between the presence of CNV (rare or common), the overall number of CNVs or genomic CNV 'burden' and antidepressant response. Specific CNVs were nominally associated with antidepressant response, including 15q13.3 duplications and exonic NRXN1 deletions. These were associated with poor response to antidepressants. Overall burden of CNVs is unlikely to contribute to personalising antidepressant treatment. Specific CNVs associated with antidepressant treatment require replication and further study to confirm their role in the therapeutic action of antidepressant.

学科与关键词

关键词
antidepressantcopy number variantsmajor depressive disorderpsychiatrytreatment response15q13.3
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
PHARMACOGENOMICS JOURNAL
发表日期
2014-08
卷期
第 14 卷, 第 4 期
页码
395-399
DOI
10.1038/tpj.2013.51
语言
ENGLISH
期刊收录
SCIE
期刊等级
Q1
成果收录
SCIE
资助标注
Wellcome Trust [086635]; Innovative Medicine Initiative Joint Undertaking (IMI-JU) [115008]; European Federation of Pharmaceutical Industries and Associations (EFPIA); European Union; European Commission, EC [LSHB-CT-2003-503428]; UK National Institute for Health Research of the Department of Health; UK Medical Research Council (MRC, UK); GlaxoSmithKline [G0701420]; Medical Research Council (MRC, UK); Mental Health Research Network; Canada Research Chair program; Wyeth-Lederle; Bristol-Myers-Squibb; Sanofi Aventis; MRC [G0800509, G0200243, MC_UU_12013/4, G0701420, G0701748] Funding Source: UKRI

作者

  • T

    Tansey, K. E. (通讯) (第一作者)

  • R

    Rucker, J. J. H.

查看全部 27 位作者收起作者
  • K

    Kavanagh, D. H.

  • G

    Guipponi, M.

  • P

    Perroud, N.

  • B

    Bondolfi, G.

  • D

    Domenici, E.

  • E

    Evans, D. M.

  • H

    Hausers, J.

  • H

    Henigsberg, N.

  • J

    Jerman, B.

  • M

    Maier, W.

  • M

    Mors, O.

  • O

    O'Donovan, M.

  • P

    Peters, T. J.

  • P

    Placentino, A.

  • R

    Rietschel, M.

    cent inst mental hlth

  • S

    Souery, D.

  • A

    Aitchison, K. J.

  • C

    Craig, I.

  • F

    Farmer, A.

  • W

    Wendland, J. R.

  • M

    Malafosse, A.

  • L

    Lewis, G.

  • K

    Kapur, S.

  • M

    McGuffin, P.

  • U

    Uher, R.

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417